Ipsen has suffered a setback in its marathon effort to bring palovarotene to market for ultra rare disease fibrodysplasia ossificans progressiva (FOP), after EU advisors recommended against approval.

Ipsen meanwhile also has another FOP candidate in its portfolio via its $535 million agreement with Blueprint in 2019 for BLU-782, an ALK2 inhibitor. FOP is caused by a mutation in the gene for ...

Battery Future Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital share exchange, asset acquisition, stock purchase, reorganization, or ...

As of 11:26:53 AM EST. Market Open.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

At close: February 20 at 9:33:46 a.m. EST ...

The Twin Cities will enjoy a quiet Thursday before strong winds on Friday and a weekend cooldown, says meteorologist Joseph Dames.

It’s one of the first actions in Washington taken by U.S. Sen. Bernie Moreno (R-Ohio), who built a network of car dealerships before entering politics. He introduced the legislation this week ...